Ownership history in Commodore Capital LP · 19 quarters on record
This page tracks every 13F SEC filing in which Commodore Capital LP reported a position in CELLDEX THERAPEUTICS INC NEW (CLDX). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 2,565,000 | -463,335 | -15.3% | 4.64% | $69.7M | $27.16 |
| 2025 Q3 | REDUCED | 3,028,335 | -421,665 | -12.2% | 3.82% | $78.3M | $25.87 |
| 2025 Q2 | ADDED | 3,450,000 | +250,000 | +7.8% | 4.96% | $70.2M | $20.35 |
| 2025 Q1 | ADDED | 3,200,000 | +1,581,063 | +97.7% | 4.28% | $58.1M | $18.15 |
As of 2025 Q4 — sorted by position size